We are live on
!
Find out more
FFIM
Founders Fund III Management Portfolio holdings
AUM
$435K
This Fund
S&P 500
This Quarter
Est. Return
-79.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$435K
AUM Growth
–
Cap. Flow
+$782K
Cap. Flow
% of AUM
179.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ensysce Biosciences
ENSC
|
+$782K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ensysce Biosciences
ENSC
$7.78M
| $435K | 100% |
+40
| New | +$782K |
|
Similar funds
ARTA
MA
LC
YEPV
AAM
CCM
IR
IFC
Founders Fund III Management's Q3 2021 Portfolio in Review
As of Q3 2021, Founders Fund III Management held 1 position worth $435K. Its ten largest holdings account for 100% of the portfolio.
Founders Fund III Management deployed $782K of net new capital in Q3 2021, opening 1 new position. Its largest new stake was Ensysce Biosciences: 40 shares worth $435K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Founders Fund III Management's largest Q3 2021 buy was Ensysce Biosciences: 40 shares worth $435K.
- Founders Fund III Management's ten largest holdings make up 100% of its $435K portfolio in Q3 2021.
- Founders Fund III Management opened 1 new position and closed 0 in Q3 2021.
Based on Founders Fund III Management's 13F filing for Q3 2021, filed 15 Nov 2021.